Pharmaceutical company scPharmaceuticals Inc. is making headway in the development and commercialization of a range of pharmaceutical products. Among its offerings is FUROSCIX, the company's lead product candidate that is comprised of a formulation of furosemide and is administered via an on-body infusor. This product is designed to target patients with heart failure and alleviate congestion. scPharmaceuticals also has scCeftriaxone, an antibiotic that targets gram-positive and gram-negative organisms, in its product pipeline, along with the scCarbapenem program, which focuses on the treatment of infections caused by gram-negative organisms. To support the development of these products, scPharmaceuticals has partnered with West Pharmaceutical Services, Inc. The two companies have a development agreement in place for the creation of a single-use SmartDose device. Founded in 2013, scPharmaceuticals is headquartered in Burlington, Massachusetts. With its promising product offerings and strong partnerships, the company is poised for continued growth and success in the pharmaceutical industry.
scPharmaceuticals's ticker is SCPH
The company's shares trade on the NASDAQ stock exchange
They are based in Burlington, MA
There are 11-50 employees working at scPharmaceuticals
It is scpharmaceuticals.com
scPharmaceuticals is in the Healthcare sector
scPharmaceuticals is in the Biotechnology industry
The following five companies are scPharmaceuticals's industry peers: